IPR Stock Overview
Produces, processes, and commercializes novel antimicrobial coating products under the Pathoglaze name. More details
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
IPERION Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | NZ$0.003 |
52 Week High | NZ$0.005 |
52 Week Low | NZ$0.003 |
Beta | 0.047 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | -62.50% |
5 Year Change | n/a |
Change since IPO | -85.00% |
Recent News & Updates
Recent updates
Shareholder Returns
IPR | NZ Chemicals | NZ Market | |
---|---|---|---|
7D | 0% | -2.6% | -1.3% |
1Y | n/a | -6.1% | 5.6% |
Return vs Industry: Insufficient data to determine how IPR performed against the NZ Chemicals industry.
Return vs Market: Insufficient data to determine how IPR performed against the NZ Market.
Price Volatility
IPR volatility | |
---|---|
IPR Average Weekly Movement | n/a |
Chemicals Industry Average Movement | 8.0% |
Market Average Movement | 4.2% |
10% most volatile stocks in NZ Market | 10.2% |
10% least volatile stocks in NZ Market | 2.9% |
Stable Share Price: IPR has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine IPR's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | n/a | iperion.co.nz |
IPERION Limited produces, processes, and commercializes novel antimicrobial coating products under the Pathoglaze name. The company’s products are used in furniture, egg cartons, kitchen chopping boards, and textiles, as well as used in automotive and hospitals sectors. IPERION Limited was formerly known as Southern Charter Financial Group Limited and changed its name to IPERION Limited in November 2023.
IPERION Limited Fundamentals Summary
IPR fundamental statistics | |
---|---|
Market cap | NZ$1.54m |
Earnings (TTM) | -NZ$812.26k |
Revenue (TTM) | n/a |
0.0x
P/S Ratio-1.9x
P/E RatioIs IPR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
IPR income statement (TTM) | |
---|---|
Revenue | NZ$0 |
Cost of Revenue | NZ$0 |
Gross Profit | NZ$0 |
Other Expenses | NZ$812.26k |
Earnings | -NZ$812.26k |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.0016 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0% |
How did IPR perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/07/03 06:51 |
End of Day Share Price | 2024/04/05 00:00 |
Earnings | 2024/03/31 |
Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
IPERION Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.